Asthma UK and Innovate UK have up to £1.25 million to invest in ideas for improving the diagnosis of asthma so patients can more quickly receive better, personalised treatment.
Improving diagnosis and treatment
Each patient’s asthma is unique and has individual triggers that vary over time.
Current tests for asthma often lead to misdiagnosis and mean patients have to receive trial treatments to find what works for them. Up to 40% of people are put on the wrong treatment initially. Diagnosing asthma in pre-school children is extremely difficult.
Asthma UK is dedicated to improving the health and well-being of the 5.4 million people in the UK whose lives are affected by asthma. It is contributing up to £750,000 to this joint funding competition, with Innovate UK investing £500,000.